Search Results - "Rabuazzo, A.M"

Effects of n -3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease by Spadaro, L, Magliocco, O, Spampinato, D, Piro, S, Oliveri, C, Alagona, C, Papa, G, Rabuazzo, A.M, Purrello, F

“…Abstract Background Long-chain polyunsaturated fatty acid omega-3 levels are decreased in the hepatic tissue of patients with nonalcoholic fatty liver disease…”
Get full text

Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications by Di Mauro, S, Ragusa, M, Urbano, F, Filippello, A, Di Pino, A, Scamporrino, A, Pulvirenti, A, Ferro, A, Rabuazzo, A.M, Purrello, M, Purrello, F, Piro, S

“…Abstract Background & aims Nonalcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease in industrialized countries. NAFLD has the…”
Get full text

Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile by Scicali, R., Di Pino, A., Platania, R., Purrazzo, G., Ferrara, V., Giannone, A., Urbano, F., Filippello, A., Rapisarda, V., Farruggia, E., Piro, S., Rabuazzo, A.M., Purrello, F.

“…Familial hypercholesterolemia (FH) is underdiagnosed and public cholesterol screening may be useful to find new subjects. In this study, we aim to investigate…”
Get full text

Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes by Calanna, S, Scicali, R, Di Pino, A, Knop, F.K, Piro, S, Rabuazzo, A.M, Purrello, F

“…Abstract Background and aims We aimed to investigate lipid abnormalities and liver steatosis in patients with HbA1c-defined prediabetes and type 2 diabetes…”
Get full text

Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries by Di Pino, A, Alagona, C, Piro, S, Calanna, S, Spadaro, L, Palermo, F, Urbano, F, Purrello, F, Rabuazzo, A.M

“…Abstract Objective We investigated the separate impact of metabolic syndrome (MS) and altered glucose tolerance on early markers of vascular injuries. Methods…”
Get full text

Hepatic insulin resistance in NAFLD: Relationship with markers of atherosclerosis and metabolic syndrome components by Privitera, G, Spadaro, L, Alagona, C, Calanna, S, Rabuazzo, A.M, Purrello, F

Get full text

HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients by Scicali, R, Di Pino, A, Gallo, A, Rosenbaum, D, Rabuazzo, A.M, Giral, P, Bruckert, E, Purrello, F

Get full text

Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction by Spadaro, L, Alagona, C, Palermo, F, Piro, S, Calanna, S, Parrinello, G, Purrello, F, Rabuazzo, A.M

“…Abstract Background and Aims Metabolic syndrome (MS) has been mainly related to insulin resistance, but the role of changes in insulin secretion has not been…”
Get full text

181 DIABETES INCREASES RENOVASCULAR IMPEDANCE IN PATIENTS WITH LIVER CIRRHOSIS by Privitera, G, Spadaro, L, Fede, G, Tomaselli, T, Russello, M, Cocuzza, C, Rabuazzo, A.M, Piro, S, Purrello, F

Get full text

Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis by Piro, S, Spadaro, L, Russello, M, Spampinato, D, Oliveri, C.E, Vasquez, E, Benigno, R, Brancato, F, Purrello, F, Rabuazzo, A.M

“…Abstract Backgrounds and aims Non-alcoholic-steatohepatitis (NASH) is closely related to insulin resistance, but it is unknown whether insulin resistance may…”
Get full text

Analysis of HDL-microRNA profile in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation by Scicali, R., Di Pino, A., Rabuazzo, A.M., Piro, S., Purrello, F.

Get full text

Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease by Bosco, G., Di Pino, A., Urbano, F., Ferrara, V., Marchisello, S., Di Mauro, S., Scamporrino, A., Filippello, A., Rabuazzo, A.M., Purrello, F., Piro, S., Scicali, R.

Get full text

Analysis Of S100A12 Plasma Levels In Hyperlipidemic Subjects With Or Without Familial Hypercholesterolemia by Scicali, R., Di Pino, A., Urbano, F., Piro, S., Rabuazzo, A.M., Purrello, F.

Get full text

High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes by Di Pino, A., Currenti, W., Urbano, F., Scicali, R., Piro, S., Purrello, F., Rabuazzo, A.M.

“…Modern diets are high in advanced glycation end-products (dAGEs), derived from processing methods, exerting a pivotal role in promoting atherosclerotic risk…”
Get full text

High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects by Scicali, D'Erasmo, L., Cluzel, P., Redheuil, A., Di Pino, A., Rabuazzo, A.M., Piro, S., Arca, M., Purrello, F., Bruckert, E., Gallo, A.

Get full text

An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects by Scicali, R., Rosenbaum, D., Di pino, A., Giral, P., Cluzel, P., Redheuil, A., Piro, S., Rabuazzo, A.M., Purrello, F., Bruckert, E., Gallo, A.

Get full text

Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity by Scamporrino, A., Di Mauro, S., Petta, S., Urbano, F., Filippello, A., Ragusa, M., Di Martino, M.T., Scionti, F., Grimaudo, S., Pipitone, R.M., Privitera, G., Di Pino, A., Scicali, R., Rabuazzo, A.M., Craxì, A., Purrello, M., Purrello, F., Piro, S.

Get full text

Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome by Zanoli, L., Di Pino, A., Terranova, V., Di Marca, S., Pisano, M., Di Quattro, R., Ferrara, V., Scicali, R., Rabuazzo, A.M., Fatuzzo, P., Castellino, P., Piro, S., Purrello, F., Malatino, L.

“…Metabolic syndrome (MetS) is currently considered to raise the risk for type 2 diabetes and cardiovascular events. It has been suggested that part of this risk…”
Get full text

738 Omega-3 polyunsaturated fatty acids: A pilot trial in non-alcoholic fatty liver disease by Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C., Alagona, C., Papa, G., Rabuazzo, A.M., Purrello, F.

Get full text

Cathepsin D and other hydrolases in the kidney of streptozotocin-diabetic mice. Possible relevance to microangiopathy by Belfiore, F, Rabuazzo, A M, Iannello, S, Campione, R, Vasta, D

“…The lysosomal enzymes cathepsin D (E.C. 3.4.23.5), alpha-glucosidase (E.C. 3.2.1.20) and beta-galactosidase (E.C. 3.2.1.23), potentially involved in the…”
Get more information